moa semaglutide GLP-1 Receptor Agonist Research Reference Mechanism of action of GLP-1

The data encompass a wide range of care settings and include patient demographics, diagnoses, procedures, medications (ordered, administered, and dispensed), laboratory and vital sign measurements, and social determinants of health (e.g., education and income, when available)

Liver fat reduction: a bonus benefit An important secondary finding from the clinical trials: after 48 weeks of treatment with the two highest doses of retatrutide, 90% of participants with elevated liver fat at baseline achieved normalization

H., Yan, B

Clinicians liken it to turning on a fat-melting switch: more GH more IGF-1 more fat breakdown

For women who use semaglutide, I emphasize adequate protein intake, strength training, and overall nutrition to help preserve muscle and support healthy aging while losing weight